{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:54:03Z","timestamp":1781416443099,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The present study aims to contribute to the available experience on the systemic use of five different anthelmintics during pregnancy (albendazole, mebendazole, praziquantel, pyrantel and pyrvinium). Particular focus was placed on the occurrence of major birth defects and pregnancy loss following first-trimester exposure. As the assessed agents differ considerably in terms of their chemical structure and mechanism of action, they were analyzed separately. A total of 282 pregnancies with exposure to the study medication were recorded in the Embryotox database (January 1, 2000\n                    <jats:bold>\u2013<\/jats:bold>\n                    February 28, 2023) and analyzed descriptively. Among 75 live-born infants with first-trimester exposure to mebendazole, five major malformations were reported, three of which were heart defects. Of the 21 live-born infants exposed to pyrantel in the first trimester, two were affected by aplasia cutis congenita of the scalp, one of whom was co-exposed to thiamazole. Among 47 live-born children with first-trimester pyrvinium exposure, one major birth defect was reported. No major malformations were observed among 4 and 10 live-born children exposed to praziquantel and albendazole, respectively. Given the limitations, the findings should be interpreted as descriptive observations and possible signals only. Further investigations with larger cohorts are required.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-57350-3","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:04:31Z","timestamp":1781413471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anthelmintic medication with focus on first-trimester exposure: an evaluation of pregnancy outcomes based on the Embryotox cohort"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8066-9384","authenticated-orcid":false,"given":"Laura","family":"Heineke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-8563","authenticated-orcid":false,"given":"Evelin","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-211X","authenticated-orcid":false,"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-5817","authenticated-orcid":false,"given":"Katarina","family":"Dathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"57350_CR1","unstructured":"World Health Organization. Soil-transmitted helminth infections [Fact sheet], https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/soil-transmitted-helminth-infections (2023)."},{"key":"57350_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.24171\/j.phrp.2023.0204","volume":"14","author":"EK Lashaki","year":"2023","unstructured":"Lashaki, E. K. et al. Global prevalence of enterobiasis in young children over the past 20 years: a systematic review and meta-analysis. Osong Public Health Res. Perspect.\u00a014, 441\u2013450. https:\/\/doi.org\/10.24171\/j.phrp.2023.0204 (2023).","journal-title":"Osong Public Health Res. Perspect."},{"key":"57350_CR3","unstructured":"National Health Service. Pregnancy, breastfeeding and fertility while taking mebendazole, https:\/\/www.nhs.uk\/medicines\/mebendazole\/pregnancy-breastfeeding-and-fertility-while-taking-mebendazole\/ (2022)."},{"key":"57350_CR4","doi-asserted-by":"publisher","DOI":"10.4103\/ijcm.ijcm","author":"R Ulaganeethi","year":"2024","unstructured":"Ulaganeethi, R. et al. Soil-transmitted helminth infection and perinatal outcomes in pregnant women in primary care settings in South India: A cohort study. Indian J. Community Med. https:\/\/doi.org\/10.3390\/tropicalmed8010048 (2024).","journal-title":"Indian J. Community Med."},{"issue":"9","key":"57350_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000291","volume":"2","author":"S Brooker","year":"2008","unstructured":"Brooker, S., Hotez, P. J. & Bundy, D. A. P. Hookworm-related anaemia among pregnant women: A systematic review. PLoS Negl. Trop. Dis. 2(9), e291. https:\/\/doi.org\/10.1371\/journal.pntd.0000291 (2008).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"57350_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2025.103133","volume":"110","author":"HM Aboelela","year":"2025","unstructured":"Aboelela, H. M. et al. Gestational intestinal parasitosis and anaemia: A double-hit for pregnancy outcomes. Parasitol. Int. 110, 103133. https:\/\/doi.org\/10.1016\/j.parint.2025.103133 (2025).","journal-title":"Parasitol. Int."},{"key":"57350_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1186\/s12884-024-07064-z","volume":"24","author":"CF Okoroafor","year":"2024","unstructured":"Okoroafor, C. F. et al. Impact of schistosomiasis infection on maternal and neonatal outcomes in pregnancy: a prospective cohort study in Nigeria. BMC Pregnancy Childbirth 24, 864. https:\/\/doi.org\/10.1186\/s12884-024-07064-z (2024).","journal-title":"BMC Pregnancy Childbirth"},{"key":"57350_CR8","unstructured":"World Health Organization. WHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee, second edition. (World Health Organization, 2025)."},{"key":"57350_CR9","unstructured":"World Health Organization. Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups, https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/2a12a9b9-a61e-460d-b1a4-59bbccd9a612\/content (2017)."},{"key":"57350_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1067\/mob.2003.79","volume":"188","author":"O Diav-Citrin","year":"2003","unstructured":"Diav-Citrin, O., Shechtman, S., Arnon, J., Lubart, I. & Ornoy, A. Pregnancy outcome after gestational exposure to mebendazole: a prospective controlled cohort study. Am. J. Obstet. Gynecol.\u00a0188, 282\u2013285. https:\/\/doi.org\/10.1067\/mob.2003.79 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"57350_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1080\/01443615.2016.1178222","volume":"36","author":"A Torp-Pedersen","year":"2016","unstructured":"Torp-Pedersen, A., Jimenez-Solem, E., Cejvanovic, V., Poulsen, H. E. & Andersen, J. T. Birth outcomes after exposure to mebendazole and pyrvinium during pregnancy\u2014A Danish nationwide cohort study. J. Obstet. Gynaecol.\u00a036, 1020\u20131025. https:\/\/doi.org\/10.1080\/01443615.2016.1178222 (2016).","journal-title":"J. Obstet. Gynaecol."},{"key":"57350_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ijpara.2019.02.005","volume":"49","author":"TW Gyorkos","year":"2019","unstructured":"Gyorkos, T. W. & St-Denis, K. Systematic review of exposure to albendazole or mebendazole during pregnancy and effects on maternal and child outcomes, with particular reference to exposure in the first trimester. Int. J. Parasitol. 49, 541\u2013554. https:\/\/doi.org\/10.1016\/j.ijpara.2019.02.005 (2019).","journal-title":"Int. J. Parasitol."},{"key":"57350_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1046\/j.1360-2276.2003.01142.x","volume":"8","author":"JO Gyapong","year":"2003","unstructured":"Gyapong, J. O., Chinbuah, M. A. & Gyapong, M. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Trop Med. Int. Health\u00a08, 1093\u20131101. https:\/\/doi.org\/10.1046\/j.1360-2276.2003.01142.x (2003).","journal-title":"Trop Med. Int. Health"},{"key":"57350_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0035-9203(01)90338-4","volume":"95","author":"M Bradley","year":"2001","unstructured":"Bradley, M. & Horton, J. Assessing the risk of benzimidazole therapy during pregnancy. Trans. R Soc. Trop. Med. Hyg. 95, 72\u201373. https:\/\/doi.org\/10.1016\/s0035-9203(01)90338-4 (2001).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"57350_CR15","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/01443615.2017.1326886","volume":"37","author":"JS Choi","year":"2017","unstructured":"Choi, J. S., Han, J. Y., Ahn, H. K., Ryu, H. M. & Koren, G. Foetal outcomes after exposure to albendazole in early pregnancy. J. Obstet. Gynaecol.\u00a037, 1108\u20131111. https:\/\/doi.org\/10.1080\/01443615.2017.1326886 (2017).","journal-title":"J. Obstet. Gynaecol."},{"key":"57350_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jtm\/taz079","volume":"27","author":"R Lau","year":"2020","unstructured":"Lau, R. et al. Treatment of soil-transmitted helminth infections in pregnancy: A systematic review and meta-analysis of maternal outcomes. J. Travel Med.\u00a027, 13. https:\/\/doi.org\/10.1093\/jtm\/taz079 (2020).","journal-title":"J. Travel Med."},{"key":"57350_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.09.22270839","author":"A Danso-Appiah","year":"2022","unstructured":"Danso-Appiah, A. et al. Safety of praziquantel in persons with and without schistosomiasis: Systematic review and meta-analysis. medRxiv https:\/\/doi.org\/10.1101\/2022.03.09.22270839 (2022).","journal-title":"medRxiv"},{"key":"57350_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2471\/BLT.17.198879","volume":"96","author":"JF Friedman","year":"2018","unstructured":"Friedman, J. F., Olveda, R. M., Mirochnick, M. H., Bustinduy, A. L. & Elliott, A. M. Praziquantel for the treatment of schistosomiasis during human pregnancy. Bull. World Health Organ. 96, 59\u201365. https:\/\/doi.org\/10.2471\/BLT.17.198879 (2018).","journal-title":"Bull. World Health Organ."},{"key":"57350_CR19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s00268-005-0015-z","volume":"29","author":"OJ Shah","year":"2005","unstructured":"Shah, O. J., Robanni, I., Khan, F., Zargar, S. A. & Javid, G. Management of biliary ascariasis in pregnancy. World J. Surg. 29, 1294\u20131298. https:\/\/doi.org\/10.1007\/s00268-005-0015-z (2005).","journal-title":"World J. Surg."},{"key":"57350_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00228-017-2351-y","volume":"74","author":"K Dathe","year":"2018","unstructured":"Dathe, K. & Schaefer, C. Drug safety in pregnancy: The German Embryotox institute. Eur. J. Clin. Pharmacol. 74, 171\u2013179. https:\/\/doi.org\/10.1007\/s00228-017-2351-y (2018).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"57350_CR21","unstructured":"European Commission Joint Research Centre. EUROCAT Guide 1.5: Instructions for the registration of congenital anomalies, https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/data-collection\/guidelines-for-data-registration_en (2025)."},{"key":"57350_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1055\/s-0034-1385857","volume":"218","author":"M Voigt","year":"2014","unstructured":"Voigt, M. et al. Neue Perzentilwerte f\u00fcr die K\u00f6rperma\u00dfe neugeborener Einlinge: Ergebnisse der deutschen Perinatalerhebung der Jahre 2007\u20132011 unter Beteiligung aller 16 Bundesl\u00e4nder. Z Geburtshilfe Neonatol. 218, 210\u2013217. https:\/\/doi.org\/10.1055\/s-0034-1385857 (2014).","journal-title":"Z Geburtshilfe Neonatol."},{"key":"57350_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-0034-1385858","volume":"218","author":"M Voigt","year":"2014","unstructured":"Voigt, M. et al. Neue Perzentilwerte f\u00fcr die K\u00f6rperma\u00dfe neugeborener Zwillinge: Ergebnisse der deutschen Perinatalerhebung der Jahre 2007\u20132011 unter Beteiligung aller 16 Bundesl\u00e4nder. Z Geburtshilfe Neonatol. 218, 254\u2013260. https:\/\/doi.org\/10.1055\/s-0034-1385858 (2014).","journal-title":"Z Geburtshilfe Neonatol."},{"key":"57350_CR24","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (2023)."},{"key":"57350_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.reprotox.2021.05.006","volume":"103","author":"S Hultzsch","year":"2021","unstructured":"Hultzsch, S. et al. First trimester naproxen exposure and outcome of pregnancy\u2014A German case series. Reprod. Toxicol.\u00a0103, 51\u201357. https:\/\/doi.org\/10.1016\/j.reprotox.2021.05.006 (2021).","journal-title":"Reprod. Toxicol."},{"key":"57350_CR26","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0140-6736(98)06308-9","volume":"353","author":"NR de Silva","year":"1999","unstructured":"de Silva, N. R., Sirisena, J. L., Gunasekera, D. P., Ismail, M. M. & de Silva, H. J. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet 353, 1145\u20131149. https:\/\/doi.org\/10.1016\/s0140-6736(98)06308-9 (1999).","journal-title":"Lancet"},{"key":"57350_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1741-4520.2005.00072.x","volume":"45","author":"N Acs","year":"2005","unstructured":"Acs, N., Banhidy, F., Puho, E. & Czeizel, A. E. Population-based case-control study of mebendazole in pregnant women for birth outcomes. Congenit. Anom.\u00a045, 85\u201388. https:\/\/doi.org\/10.1111\/j.1741-4520.2005.00072.x (2005).","journal-title":"Congenit. Anom."},{"issue":"9","key":"57350_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/01.inf.0000234068.25760.97","volume":"25","author":"TW Gyorkos","year":"2006","unstructured":"Gyorkos, T. W., Larocque, R., Casapia, M. & Gotuzzo, E. Lack of risk of adverse birth outcomes after deworming in pregnant women. Pediatr. Infect. Dis. J. 25(9), 791\u2013794. https:\/\/doi.org\/10.1097\/01.inf.0000234068.25760.97 (2006).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"57350_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3889\/oamjms.2018.143","volume":"6","author":"UB Akpan","year":"2018","unstructured":"Akpan, U. B., Asibong, U., Okpara, H. C., Monjok, E. & Etuk, S. Antenatal deworming and materno-perinatal outcomes in Calabar, Nigeria. Open Access Maced. J. Med. Sci.\u00a06, 901\u2013907. https:\/\/doi.org\/10.3889\/oamjms.2018.143 (2018).","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"57350_CR30","unstructured":"Fachinformation Johnson&Johnson (Janssen). VERMOX, 100 mg Tabletten, (2026)."},{"key":"57350_CR31","unstructured":"EUROCAT Network. Prevalence charts and tables of EUROCAT Prevalence Data, https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prevalence_en (2025)."},{"key":"57350_CR32","unstructured":"G\u00f6tz, D., Hartmann, D., K\u00f6hn, A., Vogt, C. & Ri\u00dfmann, A. Jahresbericht des Bundeslandes Sachsen-Anhalt zur H\u00e4ufigkeit von congenitalen Fehlbildungen und Anomalien sowie genetisch bedingten Erkrankungen 2024. (2024)."},{"key":"57350_CR33","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","volume":"58","author":"D van der Linde","year":"2011","unstructured":"van der Linde, D. et al. Birth prevalence of congenital heart disease worldwide. J. Am. Coll. Cardiol.\u00a058, 2241\u20132247. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.025 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"57350_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/BF00608219","volume":"30","author":"SE Marriner","year":"1986","unstructured":"Marriner, S. E., Morris, D. L., Dickson, B. & Bogan, J. A. Pharmacokinetics of albendazole in man. Eur. J. Clin. Pharmacol. 30, 705\u2013708. https:\/\/doi.org\/10.1007\/BF00608219 (1986).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"57350_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/tvjl.2001.0628","volume":"163","author":"BP Capece","year":"2002","unstructured":"Capece, B. P. et al. Placental transfer of albendazole sulphoxide enantiomers in sheep. Vet. J. 163, 155\u2013160. https:\/\/doi.org\/10.1053\/tvjl.2001.0628 (2002).","journal-title":"Vet. J."},{"key":"57350_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0035-9203(01)90164-6","volume":"95","author":"H Torlesse","year":"2001","unstructured":"Torlesse, H. & Hodges, M. Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone). Trans. R. Soc. Trop. Med. Hyg.\u00a095, 195\u2013201. https:\/\/doi.org\/10.1016\/s0035-9203(01)90164-6 (2001).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"57350_CR37","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1001\/jama.294.16.2032-c","volume":"294","author":"AM Elliott","year":"2005","unstructured":"Elliott, A. M. et al. Helminth infection during pregnancy and development of infantile eczema. JAMA 294, 2032\u20132034. https:\/\/doi.org\/10.1001\/jama.294.16.2032-c (2005).","journal-title":"JAMA"},{"key":"57350_CR38","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4269\/ajtmh.2008.79.856","volume":"79","author":"R Ndyomugyenyi","year":"2008","unstructured":"Ndyomugyenyi, R., Kabatereine, N., Olsen, A. & Magnussen, P. Efficacy of ivermectin and albendazole alone and in combination for treatment of soil-transmitted helminths in pregnancy and adverse events: A randomized open label controlled intervention trial in Masindi district, western Uganda. Am. J. Trop. Med. Hyg. 79, 856\u2013863 (2008).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"57350_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/649924","volume":"50","author":"J Ndibazza","year":"2010","unstructured":"Ndibazza, J. et al. Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: A randomized controlled trial. Clin. Infect. Dis. 50, 531\u2013540. https:\/\/doi.org\/10.1086\/649924 (2010).","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"57350_CR40","first-page":"176","volume":"8","author":"DP Urassa","year":"2011","unstructured":"Urassa, D. P., Nystrom, L. & Carlsted, A. Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: A cluster randomised controlled trial. East Afr. J. Public Health 8(3), 176\u2013184 (2011).","journal-title":"East Afr. J. Public Health"},{"key":"57350_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(04)17023-2","volume":"364","author":"P Christian","year":"2004","unstructured":"Christian, P., Khatry, S. K. & West, K. P. Jr. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 364, 981\u2013983. https:\/\/doi.org\/10.1016\/S0140-6736(04)17023-2 (2004).","journal-title":"Lancet"},{"key":"57350_CR42","first-page":"211","volume":"40","author":"T Liabsuetrakul","year":"2009","unstructured":"Liabsuetrakul, T. et al. Epidemiology and the effect of treatment of soil-transmitted helminthiasis in pregnant women in southern Thailand. Southeast Asian J. Trop. Med. Public Health 40, 211\u2013222 (2009).","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"57350_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cpt1976196802","volume":"19","author":"TC Smith","year":"1976","unstructured":"Smith, T. C., Kinkel, A. W., Gryczko, C. M. & Goulet, J. R. Absorption of pyrvinium pamoate. Clin. Pharmacol. Ther. 19, 802\u2013806. https:\/\/doi.org\/10.1002\/cpt1976196802 (1976).","journal-title":"Clin. Pharmacol. Ther."},{"key":"57350_CR44","unstructured":"Fachinformation Bayer Vital GmbH. Biltricide\u00ae, 600 mg Filmtabletten, (2022)."},{"key":"57350_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1473-3099(15)00345-X","volume":"16","author":"RM Olveda","year":"2016","unstructured":"Olveda, R. M. et al. Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: A phase 2, randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 16, 199\u2013208. https:\/\/doi.org\/10.1016\/S1473-3099(15)00345-X (2016).","journal-title":"Lancet Infect. Dis."},{"key":"57350_CR46","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1017\/S0031182011001053","volume":"138","author":"AM Elliott","year":"2011","unstructured":"Elliott, A. M. et al. Treatment with anthelminthics during pregnancy: What gains and what risks for the mother and child?\u00a0Parasitology 138, 1499\u20131507. https:\/\/doi.org\/10.1017\/S0031182011001053 (2011).","journal-title":"Parasitology"},{"key":"57350_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107253","volume":"149","author":"J Gerstenberg","year":"2024","unstructured":"Gerstenberg, J. et al. Safety and efficacy of praziquantel in pregnant women infected with Schistosoma haematobium in Lambar\u00e9n\u00e9, Gabon\u2014Clinical results from the randomized, single-blinded, controlled freeBILy-Gabon trial. Int. J. Infect. Dis. 149, 107253. https:\/\/doi.org\/10.1016\/j.ijid.2024.107253 (2024).","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"57350_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1179\/136485905x17407","volume":"99","author":"I Adam","year":"2005","unstructured":"Adam, I., Elwasila, E. & Homeida, M. Praziquantel for the treatment of schistosomiasis mansoni during pregnancy. Ann. Trop. Med. Parasitol. 99(1), 37\u201340. https:\/\/doi.org\/10.1179\/136485905x17407 (2005).","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"57350_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.trstmh.2004.01.001","volume":"98","author":"I Adam","year":"2004","unstructured":"Adam, I., el Elwasila, T. & Homeida, M. Is praziquantel therapy safe during pregnancy?. Trans. R. Soc. Trop. Med. Hyg. 98, 540\u2013543. https:\/\/doi.org\/10.1016\/j.trstmh.2004.01.001 (2004).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"57350_CR50","first-page":"91","volume":"93","author":"PW Paparone","year":"1996","unstructured":"Paparone, P. W. & Menghetti, R. A. Case report: neurocysticercosis in pregnancy. New Jersey Med. 93(2), 91\u201394 (1996).","journal-title":"New Jersey Med."},{"issue":"6","key":"57350_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s15010-014-0684-3","volume":"42","author":"BT Schleenvoigt","year":"2014","unstructured":"Schleenvoigt, B. T. et al. Placental Schistosoma haematobium infection in a German returnee from Malawi. Infection 42(6), 1061\u20131064. https:\/\/doi.org\/10.1007\/s15010-014-0684-3 (2014).","journal-title":"Infection"},{"key":"57350_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw076","author":"M Mazzitelli","year":"2016","unstructured":"Mazzitelli, M. et al. A case report of Schistosoma haematobium infection in a pregnant migrant raises concerns about lack of screening policies. J. Travel Med. https:\/\/doi.org\/10.1093\/jtm\/taw076 (2016).","journal-title":"J. Travel Med."},{"key":"57350_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/jtm.12165","volume":"22","author":"E Ben-Chetrit","year":"2015","unstructured":"Ben-Chetrit, E. et al. Schistosomiasis in pregnant travelers: A case series. J. Travel Med.\u00a022, 94\u201398. https:\/\/doi.org\/10.1111\/jtm.12165 (2015).","journal-title":"J. Travel Med."},{"issue":"5","key":"57350_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1473-3099(16)30009-3","volume":"16","author":"C Qian","year":"2016","unstructured":"Qian, C. & Gong, F. Praziquantel for schistosomiasis in pregnancy. Lancet Infect. Dis. 16(5), 525\u2013526. https:\/\/doi.org\/10.1016\/S1473-3099(16)30009-3 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"57350_CR55","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/bdd.2510150610","volume":"15","author":"AA Fasanmade","year":"1994","unstructured":"Fasanmade, A. A., Akanni, A. O., Olaniyi, A. A., Fasanmade, A. A. & Tayo, F. Bioequivalence of pyrantel pamoate dosage forms in healthy human subjects. Biopharm Drug Dispos\u00a015, 527\u2013534. https:\/\/doi.org\/10.1002\/bdd.2510150610 (1994).","journal-title":"Biopharm Drug Dispos"},{"key":"57350_CR56","unstructured":"Brackenrich J, S. H., Brown A. Aplasia Cutis Congenita., https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535403\/ (2025)."},{"key":"57350_CR57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/jdv.18690","volume":"37","author":"A Coi","year":"2023","unstructured":"Coi, A. et al. Epidemiology of aplasia cutis congenita: A population-based study in Europe. J. Eur. Acad. Dermatol. Venereol.\u00a037, 581\u2013589. https:\/\/doi.org\/10.1111\/jdv.18690 (2023).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"57350_CR58","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/s0022-3476(82)80346-6","volume":"101","author":"MJ Stephan","year":"1982","unstructured":"Stephan, M. J., Smith, D. W., Ponzi, J. W. & Alden, E. R. Origin of scalp vertex aplasia cutis. J. Pediatr.\u00a0101, 850\u2013853. https:\/\/doi.org\/10.1016\/s0022-3476(82)80346-6 (1982).","journal-title":"J. Pediatr."},{"key":"57350_CR59","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1210\/jc.2013-2831","volume":"98","author":"SL Andersen","year":"2013","unstructured":"Andersen, S. L., Olsen, J., Wu, C. S. & Laurberg, P. Birth defects after early pregnancy use of antithyroid drugs: A Danish nationwide study. J. Clin. Endocrinol. Metab.\u00a098, 4373\u20134381. https:\/\/doi.org\/10.1210\/jc.2013-2831 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57350_CR60","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","volume":"397","author":"S Quenby","year":"2021","unstructured":"Quenby, S. et al. Miscarriage matters: The epidemiological, physical, psychological, and economic costs of early pregnancy loss. The Lancet\u00a0397, 1658\u20131667. https:\/\/doi.org\/10.1016\/S0140-6736(21)00682-6 (2021).","journal-title":"The Lancet"},{"key":"57350_CR61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/bdra.23014","volume":"94","author":"L Ammon Avalos","year":"2012","unstructured":"Ammon Avalos, L., Galindo, C. & Li, D.-K. A systematic review to calculate background miscarriage rates using life table analysis. Birth Defects Res. A 94, 417\u2013423. https:\/\/doi.org\/10.1002\/bdra.23014 (2012).","journal-title":"Birth Defects Res. A"},{"key":"57350_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJM198807283190401","volume":"319","author":"AJ Wilcox","year":"1988","unstructured":"Wilcox, A. J. et al. Incidence of early loss of pregnancy. N. Engl. J. Med. 319, 189\u2013194. https:\/\/doi.org\/10.1056\/NEJM198807283190401 (1988).","journal-title":"N. Engl. J. Med."},{"key":"57350_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00404-018-4792-7","volume":"298","author":"S Celik","year":"2018","unstructured":"Celik, S. et al. Analysis of factors affecting outcomes of pregnancy complicated by Echinococcus: An algorithm for approach and management. Arch. Gynecol. Obstet. 298, 103\u2013110. https:\/\/doi.org\/10.1007\/s00404-018-4792-7 (2018).","journal-title":"Arch. Gynecol. Obstet."},{"key":"57350_CR64","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.fertnstert.2008.01.051","volume":"91","author":"EA Pritts","year":"2009","unstructured":"Pritts, E. A., Parker, W. H. & Olive, D. L. Fibroids and infertility: An updated systematic review of the evidence. Fertil. Steril. 91, 1215\u20131223. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.01.051 (2009).","journal-title":"Fertil. Steril."},{"key":"57350_CR65","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(10)62233-7","volume":"377","author":"V Flenady","year":"2011","unstructured":"Flenady, V. et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. The Lancet 377, 1331\u20131340. https:\/\/doi.org\/10.1016\/S0140-6736(10)62233-7 (2011).","journal-title":"The Lancet"},{"key":"57350_CR66","unstructured":"Deutsches \u00c4rzteblatt. Anteil der Fr\u00fchchen geht weiter zur\u00fcck. https:\/\/www.aerzteblatt.de\/news\/anteil-der-fruhchen-geht-weiter-zuruck-1feb8b12-da3f-47a3-88ef-90135ee070cb (2025)"},{"key":"57350_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","volume":"26","author":"C Schaefer","year":"2008","unstructured":"Schaefer, C., Ornoy, A., Clementi, M., Meister, R. & Weber-Schoendorfer, C. Using observational cohort data for studying drug effects on pregnancy outcome\u2014Methodological considerations. Reprod. Toxicol. 26, 36\u201341. https:\/\/doi.org\/10.1016\/j.reprotox.2008.05.064 (2008).","journal-title":"Reprod. Toxicol."},{"key":"57350_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.reprotox.2016.11.019","volume":"67","author":"E Beck","year":"2017","unstructured":"Beck, E., Lechner, A. & Schaefer, C. Who seeks Teratology Information Service\u2019s advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy. Reprod. Toxicol. 67, 79\u201384. https:\/\/doi.org\/10.1016\/j.reprotox.2016.11.019 (2017).","journal-title":"Reprod. Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57350-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:19:33Z","timestamp":1781414373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57350-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individuals included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"18373"}}